Pharmacy revenue generally is a top revenue driver at most organizations, but too often it’s treated similarly to other service lines within the organization that don’t have nearly the same charging complexities and nuances nor the impact to the bottom line...Read More »
Hospitals have made significant efforts to comply with price transparency regulations due to increased civil monetary penalties from CMS, according to a recent JAMA Network Open study.Read More »
CMS recently released a list of the 43 Part B drugs and biologicals that will be included in the Medicare Prescription Drug Inflation Rebate Program for July 1–September 30.Read More »
